Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

The role of glutamate underlying treatment-resistant depression.

Full metadata record
DC Field Value Language
dc.contributor.authorKim, Jeong Seop-
dc.contributor.authorKim, Tae-Eun-
dc.contributor.authorLee, Seung-Hwan-
dc.contributor.authorKoo, Ja Wook-
dc.date.accessioned2023-08-16T09:29:02Z-
dc.date.available2023-08-16T09:29:02Z-
dc.date.issued2022-10-
dc.identifier.issn1738-1088-
dc.identifier.issn2093-4327-
dc.identifier.urihttp://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/190-
dc.description.abstractThe monoamine hypothesis has significantly improved our understanding of mood disorders and their treatment by linking monoaminergic abnormalities to the pathophysiology of mood disorders. Even 50 years after the monoamine hypothesis was established, some patients do not respond to treatments for depression, including selective serotonin reuptake drugs. Accumulating evidence shows that patients with treatment-resistant depression (TRD) have severe abnormalities in the neuroplasticity and neurotrophic factor pathways, indicating that different treatment approaches may be necessary. Therefore, the glutamate hypothesis is gaining attention as a novel hypothesis that can overcome monoamine restrictions. Glutamate has been linked to structural and maladaptive morphological alterations in several brain areas associated with mood disorders. Recently, ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, has shown efficacy in TRD treatment and has received FDA approval, revitalizing psychiatry research. However, the mechanism by which ketamine improves TRD remains unclear. In this review, we re-examined the glutamate hypothesis, bringing the glutamate system onboard to join the modulation of the monoamine systems, emphasizing the most prominent ketamine antidepressant mechanisms, such as NMDAR inhibition and NMDAR disinhibition in GABAergic interneurons. Furthermore, we discuss the animal models used in preclinical studies and the sex differences in the effects of ketamine.-
dc.language영어-
dc.language.isoENG-
dc.publisher대한정신약물학회-
dc.titleThe role of glutamate underlying treatment-resistant depression.-
dc.typeArticle-
dc.publisher.location대한민국-
dc.identifier.bibliographicCitationClinical Psychopharmacology and Neuroscience-
dc.citation.titleClinical Psychopharmacology and Neuroscience-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
Files in This Item
Appears in
Collections
연구본부 > 정서·인지 질환 연구그룹 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Koo, Ja Wook photo

Koo, Ja Wook
연구본부 (정서·인지 질환 연구그룹)
Read more

Altmetrics

Total Views & Downloads

BROWSE